558 related articles for article (PubMed ID: 3937261)
1. Platelet aggregation in whole blood: the role of thromboxane A2 and adenosine diphosphate.
Carter AJ; Heptinstall S
Thromb Haemost; 1985 Oct; 54(3):612-6. PubMed ID: 3937261
[TBL] [Abstract][Full Text] [Related]
2. Acetyl glycerylphosphorylcholine aggregates human platelets through two distinct pathways, both dependent on arachidonic acid metabolism.
Macconi D; Morzenti G; Livio M; Morelli C; Cassina G; Remuzzi G
Lab Invest; 1985 Feb; 52(2):159-68. PubMed ID: 3155816
[TBL] [Abstract][Full Text] [Related]
3. Licofelone, an inhibitor of cyclooxygenase and 5-lipoxygenase, specifically inhibits cyclooxygenase-1-dependent platelet activation.
Rotondo S; Krauze-Brzósko K; Manarini S; Evangelista V; Cerletti C
Eur J Pharmacol; 2004 Mar; 488(1-3):79-83. PubMed ID: 15044038
[TBL] [Abstract][Full Text] [Related]
4. Biochemical and pharmacological evaluation of thromboxane synthetase inhibitors.
Gorman RR
Adv Prostaglandin Thromboxane Res; 1980; 6():417-25. PubMed ID: 6247892
[No Abstract] [Full Text] [Related]
5. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
Levy-Toledano S; Maclouf J; Caen J; Bara L; Lecrubier C; Samama M
J Pharmacol; 1983; 14(2):141-50. PubMed ID: 6408316
[TBL] [Abstract][Full Text] [Related]
6. The in vitro effect of amrinone on platelet aggregation in human whole blood.
Pattison A; Eason CT; Bonner FW
Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):261-4. PubMed ID: 3083485
[TBL] [Abstract][Full Text] [Related]
7. Effects of ethanol on pathways of platelet aggregation in vitro.
Rand ML; Packham MA; Kinlough-Rathbone RL; Fraser Mustard J
Thromb Haemost; 1988 Jun; 59(3):383-7. PubMed ID: 3142075
[TBL] [Abstract][Full Text] [Related]
8. Effect of anethole dithiolthione on human platelet aggregation.
Selley ML; McGuiness JA; Bartlett MR; Ardlie NG
Arzneimittelforschung; 1992 Mar; 42(3):318-21. PubMed ID: 1497692
[TBL] [Abstract][Full Text] [Related]
9. Thromboxane (Tx) A2 receptor blockade and TxA2 synthase inhibition alone and in combination: comparison of anti-aggregatory efficacy in human platelets.
Watts IS; Wharton KA; White BP; Lumley P
Br J Pharmacol; 1991 Feb; 102(2):497-505. PubMed ID: 1826620
[TBL] [Abstract][Full Text] [Related]
10. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
Wu CC; Wang TW; Wang WY; Hsieh PW; Wu YC
Eur J Pharmacol; 2005 Dec; 527(1-3):37-43. PubMed ID: 16313903
[TBL] [Abstract][Full Text] [Related]
11. [Effect of various stimulators on cyclooxygenase activity, platelet aggregation and TxB2 synthesis after using a platelet inhibitor (Aspro Clear) in vivo and in vitro].
Gorczynska E; James M; Wegrzynowicz R; Masiak M
Wiad Lek; 1985 Jul; 38(13):920-5. PubMed ID: 3933184
[No Abstract] [Full Text] [Related]
12. Effects of etamsylate on platelet functions and arachidonic acid metabolism.
Okuma M; Takayama H; Sugiyama T; Sensaki S; Uchino H
Thromb Haemost; 1982 Dec; 48(3):330-3. PubMed ID: 6819650
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet aggregation by a new agent, Ticlopidine.
Ashida SI; Abiko Y
Thromb Haemost; 1979 Feb; 40(3):542-50. PubMed ID: 425067
[TBL] [Abstract][Full Text] [Related]
14. Role of proaggregatory and antiaggregatory prostaglandins in hemostasis. Studies with combined thromboxane synthase inhibition and thromboxane receptor antagonism.
Gresele P; Arnout J; Deckmyn H; Huybrechts E; Pieters G; Vermylen J
J Clin Invest; 1987 Nov; 80(5):1435-45. PubMed ID: 2960694
[TBL] [Abstract][Full Text] [Related]
15. Antiplatelet effects of piplartine, an alkamide isolated from Piper tuberculatum: possible involvement of cyclooxygenase blockade and antioxidant activity.
Fontenele JB; Leal LK; Silveira ER; Felix FH; Bezerra Felipe CF; Viana GS
J Pharm Pharmacol; 2009 Apr; 61(4):511-5. PubMed ID: 19298699
[TBL] [Abstract][Full Text] [Related]
16. [Mechanisms of thrombocyte aggregation in experimental hypoparathyroidism].
Chursina IuIa; Amroian EA; Khudaverdian DN
Biull Eksp Biol Med; 1986 Dec; 102(12):666-8. PubMed ID: 3801615
[TBL] [Abstract][Full Text] [Related]
17. Influence of phentolamine on platelet aggregation, thromboxane B2 production and release reaction.
Anfossi G; Trovati M; Mularoni E; Lanzio M; Massucco P; Emanuelli G
Arch Int Pharmacodyn Ther; 1988; 296():144-54. PubMed ID: 2853612
[TBL] [Abstract][Full Text] [Related]
18. Combined administration of 5-HT2 and thromboxane A2 antagonists: effects on platelet aggregation and isolated cardiac muscle.
Shaw LA; Batey AJ; Coker SJ
Br J Pharmacol; 1997 Jul; 121(5):875-82. PubMed ID: 9222543
[TBL] [Abstract][Full Text] [Related]
19. Role of thromboxane A2.
Ambler J; Birch J; Maguire ED; Wallis RB
Adv Exp Med Biol; 1985; 192():293-308. PubMed ID: 2939695
[No Abstract] [Full Text] [Related]
20. Phenylbutazone inhibition of equine platelet function.
Meyers KM; Lindner C; Katz J; Grant B
Am J Vet Res; 1979 Feb; 40(2):265-70. PubMed ID: 464364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]